Breaking News

DS Healthcare Signs Long-Term Supply Pact

By Kristin Brooks | February 10, 2014

To provide formulation, ingredients and technology for a topical product

DS Healthcare Group has signed an agreement with a global healthcare company to provide the formulation, ingredients and its technology for use in a topical product. The product when launched will be distributed by the global healthcare company under their own brand following successful development. DS Healthcare will act as the exclusive ingredient supplier for five years, which will automatically renew under certain conditions.
 
"This agreement with a leader in the global healthcare market is a clear indication of the strength of our innovation. DS Healthcare has built a reputation of excellence for our products that has led to this agreement. This is an exciting project that we believe will reach new milestones for us," said DS Healthcare president and chief executive officer Daniel Khesin.
  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems